Rafferty Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9M | Buy |
394,599
+45,740
| +13% | +$1.26M | 0.04% | 254 |
|
|
2025
Q1 | $9.89M | Sell |
348,859
-7,236
| -2% | -$205K | 0.04% | 264 |
|
|
2024
Q4 | $14.8M | Sell |
356,095
-104,869
| -23% | -$4.36M | 0.05% | 213 |
|
|
2024
Q3 | $30.8M | Buy |
460,964
+199,204
| +76% | +$13.3M | 0.11% | 108 |
|
|
2024
Q2 | $31.1M | Buy |
261,760
+18,598
| +8% | +$2.21M | 0.12% | 101 |
|
|
2024
Q1 | $25.9M | Sell |
243,162
-28,167
| -10% | -$3M | 0.1% | 113 |
|
|
2023
Q4 | $27M | Buy |
271,329
+80,487
| +42% | +$8M | 0.11% | 108 |
|
|
2023
Q3 | $19.7M | Buy |
190,842
+33,694
| +21% | +$3.48M | 0.12% | 116 |
|
|
2023
Q2 | $19.1M | Buy |
157,148
+39,299
| +33% | +$4.77M | 0.11% | 119 |
|
|
2023
Q1 | $18.1M | Buy |
117,849
+16,136
| +16% | +$2.48M | 0.12% | 117 |
|
|
2022
Q4 | $18.3M | Sell |
101,713
-18,924
| -16% | -$3.4M | 0.15% | 109 |
|
|
2022
Q3 | $14.3M | Buy |
120,637
+29,601
| +33% | +$3.5M | 0.15% | 100 |
|
|
2022
Q2 | $13M | Buy |
91,036
+2,780
| +3% | +$397K | 0.12% | 100 |
|
|
2022
Q1 | $15.2M | Buy |
88,256
+40,968
| +87% | +$7.06M | 0.09% | 135 |
|
|
2021
Q4 | $12M | Buy |
47,288
+19,369
| +69% | +$4.92M | 0.06% | 159 |
|
|
2021
Q3 | $10.7M | Sell |
27,919
-2,579
| -8% | -$993K | 0.07% | 155 |
|
|
2021
Q2 | $7.17M | Sell |
30,498
-18,565
| -38% | -$4.36M | 0.05% | 236 |
|
|
2021
Q1 | $6.43M | Buy |
49,063
+16,706
| +52% | +$2.19M | 0.04% | 238 |
|
|
2020
Q4 | $3.38M | Sell |
32,357
-40,865
| -56% | -$4.27M | 0.03% | 332 |
|
|
2020
Q3 | $5.18M | Buy |
73,222
+57,565
| +368% | +$4.07M | 0.06% | 177 |
|
|
2020
Q2 | $1.01M | Sell |
15,657
-3,490
| -18% | -$224K | 0.01% | 541 |
|
|
2020
Q1 | $573K | Sell |
19,147
-143,597
| -88% | -$4.3M | 0.02% | 308 |
|
|
2019
Q4 | $3.18M | Buy |
+162,744
| New | +$3.18M | 0.05% | 211 |
|